期刊文献+

血管紧张素(1-7)和卡托普利预处理促进糖尿病大鼠离体心脏缺血后舒张功能的恢复 被引量:2

Treatment with angiotensin-(1-7)or captopril improves postischemic diastolic function recovery of the isolated hearts of diabetic rats
原文传递
导出
摘要 目的观察血管紧张素(1-7)[AT-(1-7)]和卡托普利预处理对糖尿病大鼠心功能的影响并探讨其可能机制。方法 SD大鼠分为糖尿病对照(DM)组、糖尿病AT-(1-7)处理(DM+AT)组、糖尿病卡托普利处理(DM+Cap)组。采用Langendorff离体心脏灌流系统检测心功能,心肌缺血20 min再灌注20 min后,检测心功能指标、心肌氧化应激水平、胶原总量、胶原交联及赖氨酰氧化酶(LOX)的表达水平。结果缺血再灌注后,DM组各心功能指标较基线明显下降,DM+AT组和DM+Cap组的左心室收缩末压(LVESP)和左心室压力上升最大变化速率(+dp/dt_(max))较基线明显下降(P<0.01),但左心室压力下降最大变化速率(—dp/dt_(max))未见明显降低(P>0.05)。与DM组比较,DM+AT组和DM+Cap组丙二醛(MDA)含量显著降低,超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活力显著增高。DM+AT组和DM+Cap组心肌胶原交联百分率和LOX蛋白表达低于DM组。结论 AT-(1-7)和卡托普利预处理促进糖尿病大鼠离体心脏缺血后舒张功能的恢复,其机制可能与增强糖尿病大鼠心肌的抗氧化能力、抑制胶原交联、LOX降低有关。 Objective To explore the effects of angiotensin (AT)-(1-7) or captopril on isolated cardiac function of diabetic rats. Methods SD rats were divided into 3 groups: diabetic control group (DM), diabetic rats treated with AT-(1-7) group (DM+AT) and diabetic rats treated with captopril group (DM+Cap). Animals were killed at four weeks after induction of diabetes and/or treatment with AT-(1-7) or captopril. The isolated Langendorff-perfused rat hearts were subjected to ischemia for 20 min followed by 20 rain of reperfusion. Leff ventricular function, myocardial markers of oxidative stress, collagen concentration, cross-linked collagen and lysyl oxidase (LOX) were examined. Results Treatment with AT-(1-7) or captopril significantly improved postischemic left ventricular -dp/dtmax. The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were significantly increased, and the levels of malondialdehyde (MDA), cross-linked collagen and LOX were significantly decreased in the myocardium of (DM+ AT) and (DM+Cap) rats as compared with control rats. Conclusion Treatment with AT-(1-7) or captopril improves postischemic diastolic function recovery in diabetic hearts. The mechanism might be related to the upregulation of antioxidant enzymes, the reduction of cross-linked collagen and the expression of LOX.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第12期939-942,共4页 Chinese Journal of Diabetes
基金 浙江省自然科学基金资助项目(Y207495) 浙江省教育厅基金资助项目(20041064) 温州市科技局基金资助项目(Y20060086)
关键词 血管紧张素(1—7) 血管紧张素转换酶抑制剂 糖尿病 心脏 胶原 AT- (1-7) Angiotensin-converting enzyme inhibitor Diabetes Heart Collagen
  • 相关文献

参考文献10

  • 1Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab, 2004,30: 487-496.
  • 2Fiordaliso F, Cuccovillo I, Bianchi R, et al. Cardiovascular ox- idative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci, 2006,79 : 121-129.
  • 3Benter IF, Yousif MH, Dhaunsi GS, et al. Angiotensin-(1 -7) prevents activation of NADPH oxidase and renal vascular dys- function in diabetic hypertensive rats. Am J Nephrol,2008,28: 25-33.
  • 4Lehman TD , Ortwerth BJ. Inhibitors of advanced glycation end product-associated protein cross linking . Biochim Biophys Acta, 2001,1535:110-119.
  • 5Benter IF, Yousif MH, Cojocel C, et al. Angiotensin-(1 -7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Cite Physiol, 2007,292 : H666-H672.
  • 6Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol, 2005, 289: H1560-H1566.
  • 7Jugdutt BI, Idikio H, Uwiera RR. Angiotensin receptor block- ade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dys- function during healing after reperfused ST-elevation myocardi- al infarction. Mol Cell Biochem,2007,303:27-38.
  • 8Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci, 2006, 63: 2304-2316.
  • 9Sivakumar P, Gupta S, Sarkar S. Upregulation of lysyl oxi dase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol Cell Biochem, 2008,307 : 159-167.
  • 10Rodriguez C, Martinez-Gonzdlez J, Raposo B, et al. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res,2008, 79:7-13.

同被引文献6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部